Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1973 1
1975 6
1976 3
1977 5
1978 6
1979 14
1980 22
1981 20
1982 18
1983 10
1984 19
1985 11
1986 9
1987 7
1988 5
1989 4
1990 8
1991 9
1992 8
1993 3
1994 5
1995 11
1996 8
1997 14
1998 19
1999 14
2000 27
2001 30
2002 38
2003 35
2004 32
2005 55
2006 62
2007 65
2008 88
2009 68
2010 91
2011 92
2012 93
2013 114
2014 116
2015 102
2016 149
2017 143
2018 161
2019 199
2020 209
2021 276
2022 299
2023 264
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

2,755 results

Results by year

Filters applied: . Clear all
Page 1
Cannabinoid Cancer Biology and Prevention.
McAllister SD, Abood ME, Califano J, Guzmán M. McAllister SD, et al. J Natl Cancer Inst Monogr. 2021 Nov 28;2021(58):99-106. doi: 10.1093/jncimonographs/lgab008. J Natl Cancer Inst Monogr. 2021. PMID: 34850900 Review.
Their promise as broad-based antitumor agents in preclinical models has led to the initiation of pilot clinical trials. Session 5 of the National Cancer Institute's Cannabis, Cannabinoids and Cancer Research Symposium provides an overview of this resea …
Their promise as broad-based antitumor agents in preclinical models has led to the initiation of pilot clinical trials. Session 5 of the Nat …
Cannabinoid Signaling in Cancer.
Das S, Kaul K, Mishra S, Charan M, Ganju RK. Das S, et al. Adv Exp Med Biol. 2019;1162:51-61. doi: 10.1007/978-3-030-21737-2_4. Adv Exp Med Biol. 2019. PMID: 31332734 Review.
The family of chemical structures that interact with a cannabinoid receptor are broadly termed cannabinoids. Traditionally known for their psychotropic effects and their use as palliative medicine in cancer, cannabinoids are very versatile and are know …
The family of chemical structures that interact with a cannabinoid receptor are broadly termed cannabinoids. Traditionally kno …
Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals.
Legare CA, Raup-Konsavage WM, Vrana KE. Legare CA, et al. Pharmacology. 2022;107(3-4):131-149. doi: 10.1159/000521683. Epub 2022 Jan 28. Pharmacology. 2022. PMID: 35093949 Free article. Review.
In general, data support a role for cannabis/cannabinoids in pain, seizure disorders, appetite stimulation, muscle spasticity, and treatment of nausea/vomiting. Given the biological activities of the cannabinoids, there may be utility in treatment of central nervous …
In general, data support a role for cannabis/cannabinoids in pain, seizure disorders, appetite stimulation, muscle spasticity, and tr …
The evolution of cannabinoid receptors in cancer.
Pennant NM, Hinton CV. Pennant NM, et al. WIREs Mech Dis. 2023 Jul-Aug;15(4):e1602. doi: 10.1002/wsbm.1602. Epub 2023 Feb 7. WIREs Mech Dis. 2023. PMID: 36750231 Free PMC article. Review.
Cannabinoids have been shown to inhibit proliferation, metastasis, and angiogenesis and even restore homeostasis in a variety of models of cancer in vitro and in vivo. Cannabis and its receptors have evolved into a therapeutic treatment for cancers. This arti …
Cannabinoids have been shown to inhibit proliferation, metastasis, and angiogenesis and even restore homeostasis in a variety of mode …
Cannabinoids in the landscape of cancer.
Mangal N, Erridge S, Habib N, Sadanandam A, Reebye V, Sodergren MH. Mangal N, et al. J Cancer Res Clin Oncol. 2021 Sep;147(9):2507-2534. doi: 10.1007/s00432-021-03710-7. Epub 2021 Jul 14. J Cancer Res Clin Oncol. 2021. PMID: 34259916 Free PMC article. Review.
References of relevant literature were searched to identify additional studies to construct a narrative literature review of oncological effects of cannabinoids in pre-clinical and clinical studies in various cancer types. ...However, these effects are dependent on …
References of relevant literature were searched to identify additional studies to construct a narrative literature review of oncological eff …
Cannabis in cancer care.
Abrams DI, Guzman M. Abrams DI, et al. Clin Pharmacol Ther. 2015 Jun;97(6):575-86. doi: 10.1002/cpt.108. Epub 2015 Apr 17. Clin Pharmacol Ther. 2015. PMID: 25777363 Review.
Delta-9-tetrahydrocannabinol, the main bioactive cannabinoid in the plant, has been available as a prescription medication approved for treatment of cancer chemotherapy-induced nausea and vomiting and anorexia associated with the AIDS wasting syndrome. Cannabinoi …
Delta-9-tetrahydrocannabinol, the main bioactive cannabinoid in the plant, has been available as a prescription medication approved f …
Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases.
Ramer R, Hinz B. Ramer R, et al. Cells. 2022 Dec 16;11(24):4102. doi: 10.3390/cells11244102. Cells. 2022. PMID: 36552866 Free PMC article. Review.
The endocannabinoid system has been shown to be involved in various skin functions, such as melanogenesis and the maintenance of redox balance in skin cells exposed to UV radiation, as well as barrier functions, sebaceous gland activity, wound healing and the skin's immune …
The endocannabinoid system has been shown to be involved in various skin functions, such as melanogenesis and the maintenance of redox balan …
Cannabis and its constituents for cancer: History, biogenesis, chemistry and pharmacological activities.
Lal S, Shekher A, Puneet, Narula AS, Abrahamse H, Gupta SC. Lal S, et al. Pharmacol Res. 2021 Jan;163:105302. doi: 10.1016/j.phrs.2020.105302. Epub 2020 Nov 24. Pharmacol Res. 2021. PMID: 33246167 Review.
Cannabinoids can also enhance the efficacy of cancer therapeutics. These compounds have been used for the management of anorexia, queasiness, and pain in cancer patients. Cannabinoid based products such as dronabinol, nabilone, nabiximols, and epidyole …
Cannabinoids can also enhance the efficacy of cancer therapeutics. These compounds have been used for the management of anorex …
Cannabinoid interventions for improving cachexia outcomes in cancer: a systematic review and meta-analysis.
Simon L, Baldwin C, Kalea AZ, Slee A. Simon L, et al. J Cachexia Sarcopenia Muscle. 2022 Feb;13(1):23-41. doi: 10.1002/jcsm.12861. Epub 2021 Dec 8. J Cachexia Sarcopenia Muscle. 2022. PMID: 34881518 Free PMC article. Review.
Cancer-associated cachexia (CAC) is a wasting syndrome characterized by involuntary weight loss and anorexia. ...The effectiveness of cannabinoids alone to improve outcomes of CAC remains unclear. Low-quality evidence from both RCTs and NRSIs shows no significant be …
Cancer-associated cachexia (CAC) is a wasting syndrome characterized by involuntary weight loss and anorexia. ...The effectiveness of …
Pharmacokinetics and pharmacodynamics of cannabinoids.
Grotenhermen F. Grotenhermen F. Clin Pharmacokinet. 2003;42(4):327-60. doi: 10.2165/00003088-200342040-00003. Clin Pharmacokinet. 2003. PMID: 12648025 Review.
However, its acid metabolite THC-COOH, the non-psychotropic cannabidiol (CBD), several cannabinoid analogues and newly discovered modulators of the endogenous cannabinoid system are also promising candidates for clinical research and therapeutic uses. Cannabinoid …
However, its acid metabolite THC-COOH, the non-psychotropic cannabidiol (CBD), several cannabinoid analogues and newly discovered mod …
2,755 results

Searches related to "cannabinoid cancer"